Traduction de «research and clinical » (Néerlandais → Français) :

TERMINOLOGIE

research | wetenschappelijk onderzoek
recherche | recherche

TRADUCTIONS EN CONTEXTE

Moreover, as the competent authority, the FAMHP intends to play a catalysing role in the stimulation and conduct of high-quality clinical research (e.g. general clinical research, academic clinical research, paediatric clinical research) in Belgium on an ongoing basis.
Moreover, as the competent authority, the FAMHP intends to play a catalysing role in the stimulation and conduct of high-quality clinical research (e.g. general clinical research, academic clinical research, paediatric clinical research) in Belgium on an ongoing basis.

Zoeken op de klassieke evidence based websites voor richtlijnen (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) met de zoekterm “ ‘pneumonia’ and ‘nursing home’ “ levert geen resultaat op.
La recherche de directives sur les “evidence based websites” classiques (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) avec les termes de recherche “ ‘pneumonia’ and ‘nursing home’ “ ne donne aucun résultat.

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.

° American College of Physicians ° Primary Care - Clinical Practice Guidelines ° U.S. Preventive Services Task Force Guide to Clinical Preventive Services ° AHRQ [Agency for Healthcare Research and Quality]
° American College of Physicians ° Primary Care - Clinical Practice Guidelines ° U.S. Preventive Services Task Force Guide to Clinical Preventive Services ° National Guideline Clearinghouse ° AHRQ (Agency for Healthcare Research and Quality) ° Evidence-Based Clinical Practice Guidelines (US) - Pédiatrie

It is the R&D department’s role to protect the participants in clinical trials by giving scientific advice and evaluating, approving, monitoring and checking applications for clinical research, on the basis of sound scientific knowledge.
It is the R&D department’s role to protect the participants in clinical trials by giving scientific advice and evaluating, approving, monitoring and checking applications for clinical research, on the basis of sound scientific knowledge.

Future of Independent Academic Clinical Research in Europe, Koninklijke academie voor Geneeskunde in samenwerking met European Organisation for Research and Treatment of Cancer (EORTC) , 2 september 2010;
Future of Independent Academic Clinical Research in Europe, Académie royale de médecine en collaboration avec l’European Organisation for Research and Treatment of Cancer (EORTC), 2 septembre 2010 ;

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

Professor Ramet, voorzitter van de Belgische Vereniging voor Kindergeneeskunde (BVK), heeft het initiatief genomen een stuurgroep op te richten waarin de kinderartsen, actief in klinisch onderzoek, het FAGG, de Ethische comités, de ziekenhuisapothekers, de betrokken (farmaceutische) industrie en de Clinical Research Organisations (CRO) vertegenwoordigd zijn om binnen een tijdsschema van 6 maanden een projectplan uit te werken, inclusief het aspect financiering.
Le professeur Ramet, président de la Société Belge de Pédiatrie (SBP), a pris l’initiative de créer un groupe de pilotage au sein duquel les pédiatres, actifs dans la recherche clinique, l’AFMPS, les Comités d’éthique, les pharmaciens hospitaliers, l’industrie (pharmaceutique) concernée et les Clinical Research Organisations (CRO) sont représentés afin de développer sur une période de 6 mois un plan de projet, y compris l’aspect financement.

In the context of the National Cancer Plan and the FAMHP spearhead policy a scientific subgroup for oncology should be established within the CTTF in order to discuss critical aspects of clinical oncology research in adults and children at an advanced scientific level.
In the context of the National Cancer Plan and the FAMHP spearhead policy a scientific subgroup for oncology should be established within the CTTF in order to discuss critical aspects of clinical oncology research in adults and children at an advanced scientific level.

Op deze vergadering was België vertegenwoordigd door professor José Ramet (Universiteit Antwerpen), voorzitter van de Belgische Vereniging voor Kindergeneeskunde (BVK) en coördinator van het Belgian Paediatric Clinical Research Network (BPCRN), dat op 2 februari 2009 van start ging.
Lors de cette réunion, la Belgique était représentée par le professeur José Ramet (Université d’Anvers), président de la Société Belge de Pédiatrie (SBP) et coordinateur du Belgian Paediatric Clinical Research Network (BPCRN) qui a été lancé le 2 février 2009.